Abnormal DRE With Normal PSA: What Happens Next?
A normal PSA does not make an abnormal digital rectal exam irrelevant. DRE and PSA provide different information.
DRE vs PSA: Which Test Tells You What?
PSA is a blood test. DRE is a physical examination of the prostate's accessible surface. Neither alone can diagnose prostate cancer.
IPSS Score 20 or Higher: What It Usually Means
The International Prostate Symptom Score quantifies lower urinary tract symptoms. Scores of 20 or above are generally considered severe.
IPSS Before HoLEP: What the Score Can and Cannot Decide
IPSS helps document how severe urinary symptoms are and gives a baseline for measuring change after treatment.
Phase 1 expanded decision guides
High PSA With a Normal DRE: What Happens Next?
A normal digital rectal exam does not cancel an elevated PSA. DRE samples only part of the gland by touch and can miss cancers that do not create a palpable abnormality.
Enlarged Prostate on DRE: BPH, PSA and Next Tests
An enlarged-feeling prostate on DRE is common with BPH, but DRE is only an estimate of size and cannot establish the cause of urinary symptoms by itself.
Prostate Nodule on DRE: Why It Usually Needs Further Evaluation
A palpable prostate nodule or distinctly hard area is an abnormal DRE finding that can increase concern for prostate cancer, even when PSA is not dramatically elevated.
Tender or Boggy Prostate on DRE: What It Can Suggest
Tenderness on DRE can occur with prostatitis or pelvic pain syndromes, but the finding is not perfectly specific. Fever, urinary symptoms and systemic illness change the urgency.
DRE Before a PSA Test: Can the Exam Change PSA?
A routine DRE may cause little or no clinically important PSA change, but testing protocols vary. The main goal is consistency and following the laboratory or clinician's preparation instructions.
Abnormal DRE but Negative Prostate MRI: What Comes Next?
A negative MRI can lower risk, but an abnormal DRE may keep clinical suspicion elevated. The next step depends on PSA density, exam quality, MRI quality, age and prior biopsy history.
DRE vs Prostate MRI: What Each Test Can and Cannot See
DRE is a quick physical exam that can detect some palpable abnormalities. MRI images the whole gland in much more detail and can identify lesions that cannot be felt.
IPSS 8–19: What a Moderate Symptom Score Usually Means
An IPSS from 8 to 19 is generally categorized as moderate lower urinary tract symptoms. Treatment depends on bother, complications, prostate anatomy and what has already been tried.
IPSS 20–35: What a Severe Score Changes
An IPSS from 20 to 35 is generally considered severe. That raises the priority of assessing how symptoms affect sleep, daily function and the risk of urinary complications.
IPSS Quality-of-Life Score: Why the 'Bother' Question Matters
The IPSS includes a quality-of-life question asking how a person would feel if urinary symptoms stayed the same. That answer can be as important as the symptom total when choosing treatment.
IPSS vs Prostate Size: Why Symptoms Do Not Track Perfectly With Volume
IPSS measures symptoms; prostate volume measures anatomy. A large prostate can cause few symptoms, while a smaller gland or bladder problem can produce substantial symptoms.
IPSS vs Uroflowmetry: Symptoms vs Measured Urine Flow
IPSS is a patient-reported symptom questionnaire. Uroflowmetry measures urinary flow. They can disagree because symptoms are influenced by bladder sensation, behavior and obstruction in different ways.
IPSS Before TURP: What the Score Adds to Procedure Planning
Before TURP, IPSS documents baseline symptom severity and helps measure response after treatment. It does not replace evaluation of prostate anatomy, flow, residual urine and complications.
IPSS Before UroLift: Who Needs More Than a Symptom Score?
IPSS is useful before a prostatic urethral lift, but anatomy matters. Median lobe configuration, prostate size, retention history and treatment goals can affect suitability.
IPSS Before Rezūm: Symptom Severity, Anatomy and Expectations
IPSS provides a baseline before water-vapor therapy for BPH. Procedure choice still depends on prostate anatomy, urinary retention, goals and local expertise.
IPSS After BPH Medication: How Much Improvement Is Meaningful?
Repeating IPSS after starting BPH medication provides a structured way to measure whether symptoms actually improved. The score should be interpreted alongside side effects and quality-of-life change.
Weak Stream and Incomplete Emptying on IPSS: What to Test Next
Weak stream and incomplete emptying are voiding symptoms that can reflect bladder outlet obstruction, weak bladder contraction or both. The symptom score cannot determine which mechanism is responsible.